Clinical trial
Nasal Calcitonin in the Treatment of Bone Mineral Loss in Children and…
NCT00114803 · Boston Children's Hospital, Other · Completed
Key facts
| NCT number | NCT00114803 |
|---|---|
| Title | Nasal Calcitonin in the Treatment of Bone Mineral Loss in Children and Adolescents With Inflammatory Bowel Disease |
| Official title | Use of Intranasally Administered Calcitonin in the Treatment of Osteopenia and Osteoporosis in Children, Adolescents and Young Adults With IBD: A Pilot Study |
| Lead sponsor | Boston Children's Hospital, Other |
| Collaborators | Crohn's and Colitis Foundation National Institutes of Health (NIH) NIH |
| Status | Completed |
| Study type | Interventional |
| Conditions | Ulcerative Colitis, Crohn's Disease |
| Intervention type | Drug |
| Interventions | Calcitonin nasal spray (salmon) |
| Enrollment | 66 |
| Start date | Jan 1, 2004 |
| Completion | Oct 1, 2006 |
| First posted | Jun 20, 2005 |
| Last update posted | Dec 5, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: